Последно актуализиране :
19/11/2024
Антибиотик   Penicillin G sodium  
Инжекция/Инжекционен
Стабилност на разтвори Стабилност на смеси Фактори, повлияващи стабилността Съвместимост Път на въвеждане Библиография Pdf
   Химична структура  

Търговско наименование   Търговско наименование     

Търговските имена са примерни и съставът на помощните вещества може да бъде различен в зависимост от държавата и лабораториите

Benapen Бразилия
Bencilpenicilina Еквадор, Перу, Чили
Benpen Австралия, нова Зеландия
Bensylpenicillin Швеция
Benzapen Иран
Benzatec Южноафриканска република / ЮАР
Benzatron Бразилия
Benzylpenicillin Дания, Египет, Норвегия, Финландия, Швеция
Benzylpenicilline Тунис
Biconcillina Еквадор
Crystapen Великобритания, Ирландия, Канада
Declin Мексико
Fortepen Саудитска Арабия
Geepenil Финландия
Natrium penicillin G Холандия
Novopen Южноафриканска република / ЮАР
Pebencil Венецуела
Penbendox Мексико
Penibiot Испания
Penicillin Норвегия
Penicillina G sodica Аржентина, Еквадор, Колумбия, Португалия, Чили
Penilevel Испания
Sodiopen Испания
Unicillina Испания
Библиография   Инжекция/Инжекционен   Библиография : Penicillin G sodium  
Вид Публикация
13 Списание Stiles ML, Allen LV.
Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs.
Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440 Списание Stiles ML, Tu YH, Allen LV.
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057 Списание Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072 Списание Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241 Списание Rayani S, Jamali F.
The stability of penicillin G sodium in 5% dextrose in water minibags after freezing.
Can J Hosp Pharm 1985 ; 38: 162-163.
1263 Списание Allwood MC, Brown PW.
The effect of buffering on the stability of reconstituted benzylpenicillin injection.
Int J Pharm Pract 1992 ; 1: 242-244.
1725 Списание Oliver C, Law S.
Compatibility of oxytocin, zidovudine, and penicillin G.
Can J Hosp Pharm 2001 ; 54: 112-113.
2056 Списание Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.
Stability of benzylpenicillin during continuous home intravenous therapy.
J Antimicrob Chemother 2004 ; 53: 675-677.
2087 Списание Ferreira E, Forest JM, Hildgen P.
Compatibility of dimenhydrinate injectable by Y administration.
Pharmactuel 2004 ; 37: 17-20.
2090 Списание Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
3012 Списание Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3227 Списание Simon B, Hancu G, Gy?resi A.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520 Лаборатория Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Лаборатория Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3540 Лаборатория Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3549 Лаборатория Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3580 Лаборатория Cytarabine Accord - Résumé des caractéristiques du produit
Accord Healthcare France 2016
3585 Лаборатория Benzylpenicillin sodium - Summary of Product Characteristics
Genus Pharmaceuticals 2008
3643 Лаборатория Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3648 Списание Hossain M.A, Friciu M, Aubin S, Leclair G.
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.
Am J Health-Syst Pharm 2014 ; 71:669-673.
3674 Лаборатория Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3702 Списание McDougall D.A.J, McWhinney.
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931 Лаборатория Trimébutine (Débridat®) - Résumé des caractéristiques du produit
Pfizer Laboratoire 2016
3964 Списание Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
4154 Лаборатория Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4319 Списание Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4389 Списание Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4590 Списание Smith E.K, McWhinney MPhil B.C.
Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service.
J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603 Списание Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4831 Списание Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I.
Frequently acquired drugs in neonatal intensive care and their physical compatibility.
Acta Paediatr 2022 ;111:2307–2314. 
4837 Списание De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.

  Mentions Légales